| Name | PAK-IN-1 |
|---|---|
| Synonyms |
1-[2-[3-(2-aminopyrimidin-4-yl)-2-(2-methoxyethylamino)benzimidazol-5-yl]ethynyl]cyclohexan-1-ol
GNE-2861; GNE 2861; GNE2861 1-((1-(2-Aminopyrimidin-4-yl)-2-((2-methoxyethyl)amino)-1H-benzo[d]imidazol-6-yl)ethynyl)cyclohexan-1-ol Cyclohexanol, 1-[2-[1-(2-amino-4-pyrimidinyl)-2-[(2-methoxyethyl)amino]-1H-benzimidazol-6-yl]ethynyl] GNE 2861 ,E2380 p21 activated kinases,inhibit,Inhibitor,PAK,GNE 2861,GNE-2861,GNE 1-((1-(2-aminopyrimidin-4-yl)-2-((2-methoxyethyl)amino)-1H-benzo[d]imidazol-6-yl)ethynyl)cyclohexanol 1-[2-[1-(2-Amino-4-pyrimidinyl)-2-[(2-methoxyethyl)amino]-1H-benzimidazol-6-yl]ethynyl]cyclohexanol GNE 2861, 10 mM in DMSO |
| Description | PAK-IN-1 is a PAK inhibitor that displays group II selectivity. PAK-IN-1 inhibits PAK4, PAK5 and PAK6 with IC50s of 7.5, 36, 126 nM, respectively. |
|---|---|
| Related Catalog | |
| Target |
IC50: 7.5 nM (PAK4), 36 nM (PAK5), 126 nM (PAK6)[1] |
| In Vitro | PAK-IN-1 is compound 4 from the reference[1]. |
| References |
| Molecular Formula | C22H26N6O2 |
|---|---|
| Molecular Weight | 406.48 |